Trump nominated Dr. Erica Schwartz as CDC director 2026 on Thursday, tapping a former Navy rear admiral and deputy surgeon general from his first term to lead an agency that has cycled through four leaders in the past 12 months and remains without a Senate-confirmed director since Dr. Susan Monarez was fired last August.
Summary
- Schwartz, 57, holds a medical degree from Brown University, a law degree, and a master’s in public health from the Uniformed Services University, and spent 24 years in uniformed service including as the US Coast Guard’s chief medical officer and as deputy surgeon general from 2019 to early 2021.
- If confirmed by the Senate, she would become the agency’s second permanent director of Trump’s second term, with acting director Dr. Jay Bhattacharya expected to remain in an interim capacity during the confirmation process, which could take several months.
- Trump also simultaneously named four additional CDC and HHS leadership appointments including Sean Slovenski, former president of Walmart Health, as CDC deputy director and chief operating officer.
The CDC director 2026 nomination arrives at one of the most unstable stretches in the agency’s modern history. The CDC has had no Senate-confirmed permanent director for all but about four weeks of Trump’s second term. Monarez was confirmed in July 2025 and fired just weeks later for reportedly not complying with Health Secretary Robert F. Kennedy Jr.’s demands on vaccines and personnel. Three acting leaders followed. The 210-day Vacancies Act clock ran out on Bhattacharya’s acting designation last month.
Trump called Schwartz “a STAR!” in a Truth Social post Thursday, adding that she had “the knowledge, experience, and TOP degrees to restore the GOLD STANDARD OF SCIENCE at the CDC.” The announcement came on the same day Kennedy testified before the House Ways and Means Committee and made some of his most supportive public statements on vaccines to date, saying the measles vaccine is safe and effective “for most people.”
Schwartz served as deputy surgeon general during the COVID-19 pandemic’s early response, where she played a significant coordinating role in testing, surveillance, and emergency communication with state health officials. Dr. Jerome Adams, who was surgeon general at the time and personally selected her, described her as having “the expertise, credibility, and integrity to lead the CDC effectively.”
She has no discernible public record opposing approved vaccines, which observers have noted is a meaningful distinction from Kennedy’s previous nominees whose vaccine-skeptic positions stalled their Senate prospects. The Senate Health, Education, Labor and Pensions Committee, chaired by Sen. Bill Cassidy of Louisiana, who has expressed concerns about the administration’s vaccine policy changes, has not yet voted on surgeon general nominee Casey Means.
CDC staff expressed cautious optimism about the nomination, according to sources who spoke with NPR. Morale at the agency collapsed during a period of mass layoffs, leadership upheaval, a gunman’s attack on the Atlanta headquarters in August 2025, and a federal judge blocking efforts to reduce recommended childhood vaccines from 17 to 11.
The Senate Confirmation Calculus
Schwartz’s traditional public health and uniformed service background is designed to navigate a Senate confirmation environment shaped by the controversy around Kennedy’s broader agenda. Her nomination alongside three other appointments signals an effort to build a functional leadership team at CDC before the hurricane season that begins June 1, ahead of the midterm calendar that will make every contested Senate vote politically costly.
The broader dynamics of the Senate confirmation pipeline have direct implications for the CLARITY Act and other pending legislation, as the same Senate majority responsible for confirming Schwartz is managing multiple competing confirmation backlogs and a compressed legislative schedule.
